MIP-1α induces differential MAP kinase activation and IκB gene expression in human B lymphocytes

Journal of Interferon and Cytokine Research

Volumn 24, Issue 7, 2004, Pages 403-410

  Teague, Ryan M ^a,b   Harlan, Lisa M ^a,c   Benedict, Stephen H ^a   Chan, Marcia A ^a,d  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d AAI Development Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; STRESS ACTIVATED PROTEIN KINASE; DNA; MACROPHAGE INFLAMMATORY PROTEIN 1;

ARTICLE; AUTOREGULATION; B LYMPHOCYTE; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TONSIL; BIOSYNTHESIS; CELL MOTION; DRUG EFFECT; LYMPHOCYTE ACTIVATION; METABOLISM; PROTEIN BINDING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; B-LYMPHOCYTES; CELL MOVEMENT; DNA; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LYMPHOCYTE ACTIVATION; MACROPHAGE INFLAMMATORY PROTEIN-1; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 3242892548     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/1079990041535656     Document Type: Article

References (40)

1. NEGUS, R.P. (1996). The chemokines: cytokines that direct leukocyte migration. J. R. Soc. Med. 89, 312-314.
2. SCHALL, T.J., and BACON, K.B. (1994). Chemokines, leukocyte trafficking, and inflammation. Curr. Opin. Immunol. 6, 865-873.
3. BAGGIOLINI, M., DEWALD, B., and MOSER, B. (1997). Human chemokines: an update. Annu. Rev. Immunol. 15, 675-705.
4. PARKINSON, E.K., GRAHAM, G.J., DAUBERSIES, P., BURNS, J.E., HEUFLER, C., PLUMB, M., SCHULER, G., and PRAGNELL, I.B. (1993). Hemopoietic stem cell inhibitor (SCI/MIP-1α) also inhibits clonogenic epidermal keratinocyte proliferation. J. Invest. Dermatol. 101, 113-117.
5. + T cells. Science 270, 1811-1815.
6. ROLLINS, B.J. (1997). Chemokines. Blood 90, 909-928.
7. ZOU, Y.R., KOTTMAN, A.H., KURODA, M., TANIUCHI, I., and LITTMAN, D.R. (1998). Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393, 595-599.
8. TACHIBANA, K., HIROTA, S., IIZASA, H., YOSHIDA, H., KAWABATA, K., KATAOKA, Y., KITAMURA, Y., MATSUSHIMA, K., YOSHIDA, N., NISHIKAWA, S.-I., KISHIMOTO, T., and NAGASAWA, T. (1998). The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393, 591-594.
9. BROXMEYER, H.E., KIM, C.H., COOPER, S.H., HANGOC, G., HROMAS, R., and PELUS, L.M. (1999). Effects of CC, CXC, C, and CX3C chemokines on proliferation of myeloid progenitor cells, and insights into SDF-1-induced chemotaxis of progenitors. Ann. NY Acad. Sci. 872, 142-162.
10. BROXMEYER, H.E., ORAZI, A., HAGUE, N.L., SLEDGE, G.W., RASMUSSEN, H., and GORDON, M.S. (1998). Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1α, in a phase I clinical trial in patients with relapsed/refractory breast cancer. Blood Cells Mol. Dis. 1, 14-30.
11. SCHALL, T.J., BACON, K., CAMP, R.D., KASPARI, J.W., and GOEDDEL, D.V. (1993). Human macrophage inflammatory protein-1α (MIP-1α) and MIP-1β chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177, 1821-1826.
12. WONG, M., and FISH, E.N. (1998). RANTES and MIP-1α activate Stats in T cells. J. Biol. Chem. 273, 309-314.
13. OMOIKE, O.I., TEAGUE, R.M., BENEDICT, S.H., and CHAN, M.A. (2000). MIP-1α induces binding of nuclear factors to the κB DNA element in human B cells. Mol. Cell Biol. Res. Commun. 4, 15-19.
14. RUMSEY, L.M., TEAGUE, R.M., BENEDICT, S.H., and CHAN, M.A. (2001). MIP-1α induces activation of phosphatidylinositol-3 kinase that associates with Pyk-2 and is necessary for B cell migration. Exp. Cell Res. 268, 77-83.
15. KIM, C.H., PELUS, M.L., WHITE, J.R., APPLEBAUM, E., JOHANSON, K., and BROXMEYER, H.E. (1998). CKβ-11/macrophage inflammatory protein-3β/ EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells. J. Immunol. 160, 2418-2424.
16. KIMATA, H., YOSHIDA, A., ISHIOKA, C., FUJIMOTO, M., LINDLEY, I., and FURUSHO, K. (1996). RANTES and macrophage inflammatory protein-1α selectively enhance immunoglobulin (IgE) and IgG4 production by human B cells. J. Exp. Med. 183, 2397-2402.
17. JIANG, A., CRAXTON, A., KUROSAKI, T., and CLARK, E. (1998). Different protein tyrosine kinases are required for B cell antigen receptor-mediated activation of extracellular signal-regulated kinase, c-Jun NH2-terminal kinase 1, and p38 mitogen-activated protein kinase. J. Exp. Med. 188, 1297-1306.
18. HASHIMOTO, A., OKADA, H., JIANG, A., KUROSAKI, M., GREENBERG, S., CLARK, E., and KUROSKI, T. (1998). Involvement of guanosine triphosphatases and phospholipase-C-γ2 in extracellular signal-regulated kinase, c-Jun NH2-terminal kinase, and p38 mitogen-activated protein kinase activation by the B cell antigen receptor. J. Exp. Med. 188, 1287-1295.
19. SUTHERLAND, C., HEATH, A., PELECH, S., YOUNG, P., and GOLD, M. (1996). Differential activation of the ERK, JNK and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. J. Immunol. 157, 3381-3390.
20. GRAMMER, A., SWANTEK, J., McFARLAND, R., MIURA, Y., GEPPERT, T., and LIPSKY, P. (1998). TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells. J. Immunol. 161, 1183-1193.
21. KASHIWADA, M., SHIRAKATA, Y., INOUE, J., NAKANO, H., OKAZAKI, K., OKUMURA, K., YAMAMOTO, T., NAGAOKA, H., and TAKEMORI, T. (1998). Tumor necrosis factor receptor-associated factor 6 (TRAF6) stimulates extracellular signal-regulated kinase (ERK) activity in CD40 signaling along a Ras-independent pathway. J. Exp. Med. 187, 237-244.
22. SUGDEN, P., and CLERK, A. (1997). Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signaling 9, 337-351.
23. KNALL, C., YOUNG, S., NICK, J., BUHL, A., WORTHEN, S., and JOHNSON, G. (1996). Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils. J. Biol. Chem. 271, 2832-2838.
24. YONEZAWA, A., HORI, T., SAKAIDA, H., and UCHIYAMA, T. (2000). SDF-1 has costimulatory effects on human T cells: possible involvement of MAPK (ERK2) activation. Microbiol. Immunol. 44, 135-141.
25. MAJKA, M., RATAJCZAK, J., KOWALSKA, A., and RATAJCZAK, M. (2000). Binding of stromal derived factor-1α (SDF-1α) to CXCR4 chemokine receptor in normal human megakaryoblasts but not in platelets induces phosphorylation of mitogen-activated protein kinase p42/44 (MAPK), ELK-1 transcription factor and serine/threonine kinase AKT. Eur. J. Haematol. 64, 164-172.
26. SULLIVAN, S., McGRATH, D., LIAO, F., BOEHME, S., FARBER, J., and BACON, K. (1999). MIP-3α induces human eosinophil migration and activation of the mitogen-activated protein kinases (P42/p44 MAPK). J. Leukocyte Biol. 66, 674-682.
27. YEN, H., ZHANG, Y., PENFOLD, S., and ROLLINS, B. (1997). MCP-1-mediated chemotaxis requires activation of non-overlapping signal transduction pathways. J. Leukocyte Biol. 61, 529-532.
28. KAMPEN, G., STAFFORD, S., ADACHI, T., JINQUAN, T., QUAN, S., GRANT, J., SKOV, P., POULSEN, L., and ALAM, R. (2000). Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood 95, 1911-1917.
29. DIKIC, I., TOKIWA, G., LEV, S., COURTNEIDGE, S., and SCHLESSINGER, J. (1996). A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 383, 547-550.
30. SIEG, D., LIIC, D., JONES, K., DAMSKY, C., HUNTER, T., and SCHLAEPFER, D. (1998). Pyk2 and Src-family protein-tyrosine kinases compensate for the loss of FAK in fibronectin-stimulated signaling events but Pyk2 does not fully function to enhance FAK-cell migration. EMBO J. 17, 5933-5947.
31. BAEUERLE, P.A., and BALTIMORE, D. (1988). IκB: a specific inhibitor of the NF-κB transcription factor. Science 242, 540-546.
32. BAEUERLE, P.A., and BALTIMORE, D. (1996). NF-κB: ten years after. Cell 87, 13-20.
33. FOETTA, V., SEGAL, D., and COHEN, D. (1998). Transcriptional regulation in the immune system: all roads lead to AP-1. J. Leukocyte Biol. 63, 139-152.
34. CHAN, M., McGRATH, T., and GELFAND, E. (1993). Regulation of the B cell immune response: induction of competence and progression in a surface IgM-bearing subset. Cell. Immunol. 146, 300-312.
35. OMOIKE, O.I., BENSON, B., CHAN, M.A., and BENEDICT, S.H. (1999). Sequences at the 3′ side of the c-fos SRE mediate gene expression via an Sob1-dependent, TCP-independent pathway. Biochem. Biophys. Res. Commun. 262, 523-529.
36. BENEDICT, S.H., MAKI, Y., and VOGT, P. (1985). Avian retrovirus S13: properties of the genome and of the transformation-specific protein. Virology 145, 154-164.
37. FALK, W., GOODWIN, R.H., and LEONARD, E.J. (1980). A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J. Immunol. Methods 33, 239-247.
38. HEHNER, S., HOFMANN, T., DROGE, W., and SCHMITZ, M. (1999). The anti-inflammatory sesquiterpene lactone parthenolide inhibits NF-κB by targeting the IκB kinase complex. J. Immunol. 163, 5617-5623.
39. BROWN, K., PARK, S., KANNO, T., FRANZOSO, G., and SIEBENLIST, U. (1993). Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-α. Proc. Natl. Acad. Sci. USA 90, 2532-2536.
40. SUN, S., GANCHI, P., BALLARD, D., and GREENE, W. (1993). NF-κB controls expression of inhibitor I-κB: evidence for an inducible autoregulatory pathway. Science 259, 1912-1915.